| 臺大學術典藏 |
2021-03-09T01:43:10Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:09Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-02-23T08:26:42Z |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen L.-T.;Lin J.-T.;Tai J.J.;Chen G.-H.;Yeh H.-Z.;Yang S.-S.;Wang H.-P.;Sung-Hsin Kuo;Sheu B.-S.;Jan C.-M.;Wang W.-M.;Wang T.-E.;Wu C.-W.;Chen C.-L.;Su I.-J.;Whang-Peng J.;Cheng A.-L.; Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; Wang H.-P.; SUNG-HSIN KUO; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-18T08:01:13Z |
Safety of perfluorobutane (Sonazoid) in characterizing focal liver lesions
|
Chou Y.-H.; JA-DER LIANG; Wang S.-Y.; Hsu S.-J.; Hu J.-T.; Yang S.-S.; Wang H.-K.; Lee T.-Y.; Tiu C.-M. |
| 臺大學術典藏 |
2021-02-03T03:56:43Z |
Lower urinary tract symptoms in women with irritable bowel syndrome: Original Article: Clinical Investigation
|
Guo Y.-J.; Ho C.-H.; Chen S.-C.; Yang S.-S.; HAN-MO CHIU; Huang K.-H. |
| 臺大學術典藏 |
2021-02-02T02:48:03Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
Huang Y.-W.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; Chen P.-J.; PING-NING HSU; Yang S.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-02-02T02:48:02Z |
Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
Huang Y.-W.; Hsu C.-K.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; Chen P.-J.; PING-NING HSU; Yang S.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:01Z |
Assessment of ketamine uropathy
|
Yang S.S.;Wu C.-H.;Chen J.Y.J.;Chang S.-J.;Jang M.Y.;Wu W.J.;Ruan Y.S.;Li S.Y.;Wu J.S.;Chung Y.C.;Li W.J.;Li Y.H.;Tang Y.C.;Shen K.H.;Lin W.Y.;Chen J.S.;Lee M.H.;Chen M.H.;Zou J.L.;Jhang J.S.;Syu J.S.;Yang S.S.;Chang S.J.;Lin A.T.L.;Fan Y.H.;Meng E.;Syu Y.J.;Hong-Jeng Yu;Guo Y.C.;Ye J.S.;Wang Y.J.;Jhang J.F.;Jiang Y.H.;Kuo H.C.;Team For National Registration Of Ketamine Uropathy; Yang S.S.; Wu C.-H.; Chen J.Y.J.; Chang S.-J.; Jang M.Y.; Wu W.J.; Ruan Y.S.; Li S.Y.; Wu J.S.; Chung Y.C.; Li W.J.; Li Y.H.; Tang Y.C.; Shen K.H.; Lin W.Y.; Chen J.S.; Lee M.H.; Chen M.H.; Zou J.L.; Jhang J.S.; Syu J.S.; Yang S.S.; Chang S.J.; Lin A.T.L.; Fan Y.H.; Meng E.; Syu Y.J.; HONG-JENG YU; Guo Y.C.; Ye J.S.; Wang Y.J.; Jhang J.F.; Jiang Y.H.; Kuo H.C.; Team for National Registration of Ketamine Uropathy |
| 臺大學術典藏 |
2021-01-28T02:03:42Z |
Lower urinary tract symptoms in women with irritable bowel syndrome: Original Article: Clinical Investigation
|
Guo Y.-J.;Ho C.-H.;Chen S.-C.;Yang S.-S.;Chiu H.-M.;Kuo-How Huang; Guo Y.-J.; Ho C.-H.; Chen S.-C.; Yang S.-S.; Chiu H.-M.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-15T03:47:46Z |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; HSIU-PO WANG; Kuo S.-H.; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-06T03:39:05Z |
A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan
|
Ho W.-L.; Chung K.-P.; Yang S.-S.; Lu M.-Y.; Jou S.-T.; Chang H.-H.; YUNG-LI YANG; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2021-01-05T02:28:56Z |
A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan
|
Chung K.-P.; Ho W.-L.; Yang S.-S.; Lu M.-Y.; SHIANN-TANG JOU; Chang H.-H.; Yang Y.-L.; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2021-01-04T07:36:01Z |
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study
|
MEI-HWEI CHANG; You S.-L.; Chen C.-J.; Liu C.-J.; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-04T07:32:20Z |
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
|
You S.-L.; MEI-HWEI CHANG; Chen C.-J.; Liu C.-J.; Lai M.-W.; Wu T.-C.; Wu S.-F.; Lee C.-M.; Yang S.-S.; Chu H.-C.; Wang T.-E.; Chen B.-W.; Chuang W.-L.; Soon M.-S.; Lin C.-Y.; Chiou S.-T.; Kuo H.-S.; Chen D.-S.; Yang Y.-J.; Lo G.-H.; Kong M.-S.; Wang P.-M.; Yang C.-C.; Chu C.-H.; Lin L.-H.; Chien R.-N.; Lee T.-H.; Yang K.-C.; Liao L.-Y.; Mo L.-R.; Liu J.-D.; Yang T.-H.; Lo C.-C.; Tsai M.-H.; Chou C.-H.; Cheng Y.-S. |
| 國立成功大學 |
2021 |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang, C.-F.;Kuo, H.-T.;Chang, T.-S.;Lo, C.-C.;Hung, C.-H.;Huang, C.-W.;Chong, L.-W.;Cheng, P.-N.;Yeh, M.-L.;Peng, C.-Y.;Cheng, Cheng C.-Y.;Huang, J.-F.;Bair, M.-J.;Lin, C.-L.;Yang, C.-C.;Wang, S.-J.;Hsieh, T.-Y.;Lee, T.-H.;Lee, P.-L.;Wu, Wu W.-C.;Lin, C.-L.;Su, W.-W.;Yang, S.-S.;Wang, C.-C.;Hu, J.-T.;Mo, L.-R.;Chen, Chen C.-T.;Huang, Y.-H.;Chang, Chang C.-C.;Huang, C.-S.;Chen, G.-Y.;Kao, C.-N.;Tai, C.-M.;Liu, C.-J.;Lee, M.-H.;Tsai, P.-C.;Dai, C.-Y.;Kao, J.-H.;Lin, H.-C.;Chuang, W.-L.;Chen, Chen C.-Y.;Tseng, K.-C.;Yu, M.-L. |
| 國立成功大學 |
2021 |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen, Chen C.-Y.;Huang, C.-F.;Cheng, P.-N.;Tseng, K.-C.;Lo, C.-C.;Kuo, H.-T.;Huang, Y.-H.;Tai, C.-M.;Peng, C.-Y.;Bair, M.-J.;Chen, Chen C.-H.;Yeh, M.-L.;Lin, C.-L.;Lin, C.-Y.;Lee, P.-L.;Chong, L.-W.;Hung, C.-H.;Huang, J.-F.;Yang, C.-C.;Hu, J.-T.;Lin, C.-W.;Chen, Chen C.-T.;Wang, C.-C.;Su, W.-W.;Hsieh, T.-Y.;Lin, C.-L.;Tsai, W.-L.;Lee, T.-H.;Chen, G.-Y.;Wang, S.-J.;Chang, Chang C.-C.;Mo, L.-R.;Yang, S.-S.;Wu, Wu W.-C.;Huang, C.-S.;Hsiung, C.-K.;Kao, C.-N.;Tsai, P.-C.;Liu, C.-H.;Lee, M.-H.;Liu, C.-J.;Dai, C.-Y.;Kao, J.-H.;Chuang, W.-L.;Lin, H.-C.;Yu, M.-L. |
| 國立成功大學 |
2021 |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
Hong, C.-M.;Lin, Y.-Y.;Liu, C.-J.;Lai, Y.-Y.;Yeh, S.-H.;Yang, H.-C.;Kao, J.-H.;Hsu, S.-J.;Huang, Y.-H.;Yang, S.-S.;Kuo, H.-T.;Cheng, P.-N.;Yu, M.-L.;Chen, P.-J. |
| 國立成功大學 |
2021 |
Submillisecond Laser Annealing Induced Surface and Subsurface Restructuring of Cu-Ni-Pd Trimetallic Nanocatalyst Promotes Thermal CO2Reduction
|
Bhalothia, D.;Hsiung, W.-H.;Yang, S.-S.;Yan, C.;Chen, P.-C.;Lin, T.-H.;Wu, S.-C.;Chen, P.-C.;Wang, K.-W.;Lin, M.-W.;Chen, T.-Y. |
| 臺大學術典藏 |
2020-12-30T02:43:25Z |
IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients
|
Hsieh Y.Y.; Lu Y.T.; Chuang J.Y.; Yang S.S.; Chen C.Y.; SHAN-CHWEN CHANG; Chang C.S.; Yeh H.Z.; Kao J.H. |
| 臺大學術典藏 |
2020-12-29T05:33:52Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Yang S.-S.; Liu C.-H.; Huang Y.-J.; Liu C.-H.;Huang Y.-J.;Yang S.-S.;Chang C.-H.;Yang S.-S.;Hsin-Yun Sun;Liu C.-J.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Kao J.-H.; Hung C.-C.; Chen D.-S.; Chang C.-H.; Yang S.-S.; HSIN-YUN SUN; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-12-28T08:14:10Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Yen-Hsuan Ni;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Wang P.-M.; Chao Y.; Chen L.-T.; Hsu C.; Cheng A.-L.; Lin C.-C.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-12-18T05:28:42Z |
A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan
|
Lin K.-H.; Lin D.-T.; Yang Y.-L.; HSIU-HAO CHANG; Jou S.-T.; Lu M.-Y.; Yang S.-S.; Ho W.-L.; Chung K.-P. |
| 臺大學術典藏 |
2020-12-16T07:21:55Z |
A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan
|
Ho W.-L.; Chung K.-P.; Yang S.-S.; MENG-YAO LU; Jou S.-T.; Chang H.-H.; Yang Y.-L.; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2020-11-19T03:19:55Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:31Z |
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
|
Lin C.-W.; Lin C.-C.; Mo L.-R.; Chang C.-Y.; Perng D.-S.; Hsu C.-C.; Lo G.-H.; Chen Y.-S.; Yen Y.-C.; Hu J.-T.; Yu M.-L.; PO-HUANG LEE; Lin J.-T.; Yang S.-S. |
